Skip to main content

Table 3 Multivariate analysis of clinicopathologic factors in relation to PFS and OS of patients

From: The relationship between retroperitoneal lymphadenectomy and survival in advanced ovarian cancer patients

 

No

Progression-free survival (PFS)

Overall survival (OS)

Hazard ratio (95% CI)

P-value

Hazard ratio (95% CI)

P-value

Total

410

    

FIGO stage

 III

342

1

0.006

1

0.403

 IV

68

0.694 (0.534–0.902)

 

0.804 (0.483–1.340)

 

Histology

 Serous type

320

1

0.521

1

0.725

 Non-serous type

90

0.926 (0.731–1.172)

 

1.082 (0.697–1.680)

 

Lymphadenectomy

 No

170

1

0.237

1

0.389

 Yes

240

1.127 (0.924–1.374)

 

0.846 (0.578–1.238)